Skip to content

Clinical trials

Observational trials in Algeria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Observational Country / region: Algeria Clear all

60 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20051
20084
20093
20103
20113
20123
20132
20144
20152
20167
20172
20184
20191
20203
20213
20232
20241
20256
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed45
Recruiting7
Terminated3
Unknown status2
Not yet recruiting1
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S11
Bayer5
AstraZeneca4
Amar h Zireg3
Société Algérienne de Formation et Recherche en Oncologie3
Beker Laboratories2
Hikma Pharmaceuticals LLC2
Hoffmann-La Roche2
Janssen Pharmaceutica N.V., Belgium2
University of Algiers2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus10
Diabetes Mellitus, Type 26
Neoplasms5
Breast Neoplasms4
Hypertension3
Atrial Fibrillation2
COVID-192
Cardiovascular Diseases2
Diabetes Complications2
Diabetes Mellitus, Type 12

Trials

Showing 1 to 25 of 60. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.